NANJING, China I May 31, 2025 I Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") today announced the presentation of groundbreaking clinical data from a ...

Enantiomers, or molecule pairs that are mirror images of each other, make up more than half of FDA-approved drugs in use ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Lykos Therapeutics looked set to have the first psychedelic approved by the US Food and Drug Administration (FDA), an MDMA ...

Multibagger stock: Pharma company Sudarshan Pharma Industries share price will remain in focus in Monday's trading session after the company reported its half yearly and FY25 financial ...

and help design appropriate communications to target patient populations,” the authors noted. “These capabilities are not peripheral; they are vital to every aspect of pharma’s R&D.” In a world where ...

In his 42-year journey of building Sun Pharma from the ground up, there is only one thing Dilip Shanghvi would do differently. “Sometimes I would have got angry… That I wouldn’t have wanted ...

A Cambridge-based pharmaceutical company is laying off close to a hundred employees. Ono Pharma USA, a subsidiary of the Japanese pharmaceutical company of the same name, filed with the state last ...

Ahmedabad: Gujarat has further cemented its position as India's pharmaceutical powerhouse with the state's Food and Drug Control Administration (FDCA) approving 183 new allopathic drug ...

LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on ...

Aurobindo Pharma subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Dasatinib Tablets in different ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...